Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

PwC finds hospital and physician practice deals down in Q1

In its quarterly analysis of healthcare merger and acquisition activity, PricewaterhouseCoopers LLP, concludes that compared to the first quarter of last year, 2014 so far is fairly soft in announced deals for hospitals and physician practices even thought the incentives to merge are still strong.

Thumbnail

AtlantiCare and Geisinger health systems make merger plans official

If regulatory approval is given, AtlantiCare, southern New Jersey’s largest healthcare organization, will become a part of the Geisinger Health System sometime next year. The two organizations have signed a definitive agreement for AtlantiCare to become a member of the Geisinger Health System, and expect the regulatory approval phase to take 9 to 12 months to complete.

MedCPU Closes $9.3 Million in Series B Funding to Expand Clinical Decision Support Solutions for Healthcare Providers

NEW YORK--MedCPU, Inc., a leader in enterprise clinical decision support solutions, announced today the close of a $9.3 Million Series B funding round that will provide the company with capital to maximize its growth opportunities in the expanding market for clinical decision support solutions for healthcare providers. Investors in the B round of financing include Merck Global Health Innovation Fund, Easton Capital Investment Group and New Richmond Ventures.

Thumbnail

Dick Taylor, M.D.: ICD-10 will not do what you think it will

Dick Taylor, M.D., is a software engineer, pediatrician and chief medical officer for the Frisco, Texas, healthcare information technology consulting firm MedSys Group. He is also an outspoken critic of ICD-10. Dr. Taylor shared his perspective on why ICD-10 implementation will likely not improve healthcare data as hoped and why the one-year implementation delay is good news.

Moody’s special report confirms importance of hospitals diversifying

It’s not quite “diversify or die,” but a new report from Moody’s Investors Service on the not-for-profit hospital sector does stress the need for hospitals to expand into outpatient services, along with making investments in efficiency and information technology.

CHE Trinity partners with Walgreens in latest strategic step

Since Richard Gilfillan, M.D., left his post as director of the Centers for Medicare & Medicaid Services (CMS) Innovation Center last June to become CEO of newly merged CHE Trinity Health, the healthcare systems has made several strategic moves to align itself with changes driven by healthcare reform. The latest came this week when it announced a deal with Walgreens, the nation’s largest drugstore chain, to collaborate on clinical care and population health initiatives.

Milliman measure finds healthcare cost growth slowing to 5.4%

The annual Milliman Medical Index estimate of the projected total cost of healthcare for a hypothetical family of four is out and the good news is that the amount only increased 5.4 percent this year, the lowest rate of annual increase since Milliman first began tracking this cost in 2002. The bad news is that the cost is now up to $23,215.

Thumbnail

AHA and three hospitals sue Sebelius over appeals backlog

The backlog of appeals of recovery audit contractor (RAC) decisions “has reached a crisis point” says the American Hospital Association (AHA) and three hospitals who have brought suit against outgoing U.S. Department of Health and Human Services Secretary Kathleen Sebelius over the length of time it now takes to have an appeal of a reimbursement claim denial decided by an adiminstrative law judge.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.